LGVN
Price
$0.79
Change
+$0.04 (+5.33%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
15.56M
LSTA
Price
$2.19
Change
+$0.08 (+3.79%)
Updated
Sep 5, 04:51 PM (EDT)
Capitalization
18.66M
62 days until earnings call
Interact to see
Advertisement

LGVN vs LSTA

Header iconLGVN vs LSTA Comparison
Open Charts LGVN vs LSTABanner chart's image
Longeveron
Price$0.79
Change+$0.04 (+5.33%)
Volume$5.28K
Capitalization15.56M
Lisata Therapeutics
Price$2.19
Change+$0.08 (+3.79%)
Volume$500
Capitalization18.66M
LGVN vs LSTA Comparison Chart in %
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. LSTA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Hold and LSTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LGVN: $0.75 vs. LSTA: $2.11)
Brand notoriety: LGVN and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 61% vs. LSTA: 82%
Market capitalization -- LGVN: $15.56M vs. LSTA: $18.66M
LGVN [@Biotechnology] is valued at $15.56M. LSTA’s [@Biotechnology] market capitalization is $18.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, LGVN is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 4 TA indicator(s) are bullish while LSTA’s TA Score has 4 bullish TA indicator(s).

  • LGVN’s TA Score: 4 bullish, 6 bearish.
  • LSTA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both LGVN and LSTA are a bad buy in the short-term.

Price Growth

LGVN (@Biotechnology) experienced а -9.86% price change this week, while LSTA (@Biotechnology) price change was -10.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

LSTA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSTA($18.7M) has a higher market cap than LGVN($15.6M). LSTA YTD gains are higher at: -29.195 vs. LGVN (-56.757). LGVN has higher annual earnings (EBITDA): -18.35M vs. LSTA (-20.83M). LSTA has more cash in the bank: 22M vs. LGVN (10.3M). LSTA has less debt than LGVN: LSTA (47K) vs LGVN (1.14M). LGVN has higher revenues than LSTA: LGVN (2.07M) vs LSTA (1.07M).
LGVNLSTALGVN / LSTA
Capitalization15.6M18.7M83%
EBITDA-18.35M-20.83M88%
Gain YTD-56.757-29.195194%
P/E Ratio3.17N/A-
Revenue2.07M1.07M194%
Total Cash10.3M22M47%
Total Debt1.14M47K2,426%
FUNDAMENTALS RATINGS
LSTA: Fundamental Ratings
LSTA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGVNLSTA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEON57.851.58
+2.80%
VEON Ltd
KOS1.720.04
+2.38%
Kosmos Energy Ltd
CSGP89.101.24
+1.41%
CoStar Group
NISN3.59-0.16
-4.21%
NiSun International Enterprise Development Group Co Ltd
IRWD1.10-0.14
-11.29%
Ironwood Pharmaceuticals

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-8.31%
QURE - LGVN
37%
Loosely correlated
+2.01%
RXRX - LGVN
36%
Loosely correlated
-2.38%
SNGX - LGVN
36%
Loosely correlated
-1.30%
HRTX - LGVN
35%
Loosely correlated
-0.75%
PROK - LGVN
34%
Loosely correlated
-2.54%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-8.26%
RAIN - LSTA
29%
Poorly correlated
-8.45%
CRIS - LSTA
27%
Poorly correlated
-0.58%
LGVN - LSTA
27%
Poorly correlated
-8.31%
TPST - LSTA
26%
Poorly correlated
-4.48%
ASND - LSTA
26%
Poorly correlated
-0.94%
More